Pharmacological management of challenging behaviours in people with dementia

Australian Journal of Hospital Pharmacy

Volumn 27, Issue 1, 1997, Pages 49-57

  Peisah, Carmelle ^a  

^a PRINCE HENRY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CHLORAL HYDRATE; CHLORPROMAZINE; CLOMETHIAZOLE; DESIPRAMINE; DIAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; LOXAPINE; MIANSERIN; MORPHINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OXAZEPAM; PROPRANOLOL; RISPERIDONE; SELEGILINE; TEMAZEPAM; THIORIDAZINE; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROIC ACID;

BEHAVIOR DISORDER; DEMENTIA; DRUG CHOICE; DRUG MONITORING; HUMAN; MENTAL DISEASE; REVIEW; SYMPTOMATOLOGY;

EID: 0030898928     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr199727149     Document Type: Review

References (2)

1. Teri L, Rabins P, Whitehouse P, Berg L, Reisberg B, Sunderland T, et al. Management of behavioural disturbance in Alzheimer disease: current knowledge and future directions. Alzheimer Dis Assoc Disord 1992; 6: 77-88.
2. Schneider LS, Sobin PB. Non-neuroleptic medications in the management of agitation in Alzheimer's disease and other dementia: a selective review. Int J Geriatr Psychiatry 1991; 6: 691-708.